IL160531A0 - Compositions and methods for aa4rp assay - Google Patents
Compositions and methods for aa4rp assayInfo
- Publication number
- IL160531A0 IL160531A0 IL16053102A IL16053102A IL160531A0 IL 160531 A0 IL160531 A0 IL 160531A0 IL 16053102 A IL16053102 A IL 16053102A IL 16053102 A IL16053102 A IL 16053102A IL 160531 A0 IL160531 A0 IL 160531A0
- Authority
- IL
- Israel
- Prior art keywords
- aa4rp
- compositions
- methods
- assay
- relates
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000003556 assay Methods 0.000 title 1
- 230000000923 atherogenic effect Effects 0.000 abstract 2
- 238000011002 quantification Methods 0.000 abstract 2
- 239000000523 sample Substances 0.000 abstract 2
- 108010073614 apolipoprotein A-IV Proteins 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0111598A FR2829581A1 (fr) | 2001-09-07 | 2001-09-07 | Methodes de criblage de molecules utiles pour la prevention ou le traitement du syndrome metabolique, des maladies cardiovasculaires et de l'atherosclerose |
| FR0210205A FR2843395A1 (fr) | 2002-08-12 | 2002-08-12 | Composition et methodes pour le dosage de l'aa4rp |
| PCT/FR2002/003041 WO2003023408A1 (fr) | 2001-09-07 | 2002-09-06 | Compositions et methodes pour le dosage de l'aa4rp |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL160531A0 true IL160531A0 (en) | 2004-07-25 |
Family
ID=26213176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16053102A IL160531A0 (en) | 2001-09-07 | 2002-09-06 | Compositions and methods for aa4rp assay |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040197823A1 (de) |
| EP (1) | EP1423708B1 (de) |
| JP (1) | JP2005502711A (de) |
| AT (1) | ATE347108T1 (de) |
| CA (1) | CA2459947A1 (de) |
| DE (1) | DE60216482T2 (de) |
| DK (1) | DK1423708T3 (de) |
| ES (1) | ES2275924T3 (de) |
| IL (1) | IL160531A0 (de) |
| WO (1) | WO2003023408A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7972802B2 (en) * | 2005-10-31 | 2011-07-05 | University Of Washington | Lipoprotein-associated markers for cardiovascular disease |
| US8241861B1 (en) | 2008-07-08 | 2012-08-14 | Insilicos, Llc | Methods and compositions for diagnosis or prognosis of cardiovascular disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0976824A1 (de) * | 1998-07-10 | 2000-02-02 | Amsterdam Molecular Therapeutics | An der Leberregenration beteiligtes Gen und Protein |
| CA2354369A1 (en) * | 1998-12-22 | 2000-06-29 | Genset S.A. | Complementary dna's encoding proteins with signal peptides |
| US6455280B1 (en) * | 1998-12-22 | 2002-09-24 | Genset S.A. | Methods and compositions for inhibiting neoplastic cell growth |
| PT1623990E (pt) * | 1999-03-08 | 2008-03-18 | Genentech Inc | Composições e métodos para o tratamento de tumores |
| CA2368098A1 (en) * | 1999-06-25 | 2001-01-04 | Genset S.A. | Complementary dna's encoding proteins with signal peptides |
| CA2311201A1 (en) * | 1999-08-05 | 2001-02-05 | Genset S.A. | Ests and encoded human proteins |
| EP1276754A4 (de) * | 2000-04-14 | 2005-04-06 | Nuvelo Inc | Materialien und verfahren betreffend den lipidmetabolismus |
-
2002
- 2002-09-06 IL IL16053102A patent/IL160531A0/xx unknown
- 2002-09-06 DE DE60216482T patent/DE60216482T2/de not_active Expired - Fee Related
- 2002-09-06 US US10/487,096 patent/US20040197823A1/en not_active Abandoned
- 2002-09-06 CA CA002459947A patent/CA2459947A1/fr not_active Abandoned
- 2002-09-06 WO PCT/FR2002/003041 patent/WO2003023408A1/fr not_active Ceased
- 2002-09-06 EP EP02781373A patent/EP1423708B1/de not_active Expired - Lifetime
- 2002-09-06 ES ES02781373T patent/ES2275924T3/es not_active Expired - Lifetime
- 2002-09-06 JP JP2003527428A patent/JP2005502711A/ja active Pending
- 2002-09-06 AT AT02781373T patent/ATE347108T1/de not_active IP Right Cessation
- 2002-09-06 DK DK02781373T patent/DK1423708T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DK1423708T3 (da) | 2007-04-02 |
| EP1423708B1 (de) | 2006-11-29 |
| US20040197823A1 (en) | 2004-10-07 |
| CA2459947A1 (fr) | 2003-03-20 |
| DE60216482T2 (de) | 2007-08-23 |
| WO2003023408A1 (fr) | 2003-03-20 |
| EP1423708A1 (de) | 2004-06-02 |
| JP2005502711A (ja) | 2005-01-27 |
| ATE347108T1 (de) | 2006-12-15 |
| ES2275924T3 (es) | 2007-06-16 |
| DE60216482D1 (de) | 2007-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1379693A4 (de) | Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes | |
| WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
| DK1513878T3 (da) | Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100 | |
| WO2003064993A3 (en) | Methods and materials for detecting genetic material | |
| BG104275A (en) | Method and device for express analysis of tested parameters in biological samples | |
| CA2285918A1 (en) | Methods for concentrating ligands using magnetic particles | |
| WO2002055985A3 (en) | Methods and reagents for identifying rare fetal cells in the material circulation | |
| AU3538195A (en) | Assays and devices for the detection of extrahepatic biliary atresia | |
| WO2004019000A3 (en) | Chemical reagents and methods for detection and quantification of proteins in complex mixtures | |
| DE69939121D1 (de) | Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden | |
| WO2005003394A3 (en) | Bio-barcode based detection of target analytes | |
| AU2849300A (en) | Methods and assay kits for detecting mononuclear cell phenotype | |
| DE602004021281D1 (de) | Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren | |
| CY1107621T1 (el) | Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα | |
| EP0873998A3 (de) | Rezeptor-Protein und seine Verwendung | |
| EP0753743A3 (de) | Vitamin-D-Bestimmung | |
| CA2341263A1 (en) | Enzyme inhibition immunoassay | |
| CA2283154A1 (en) | Method and apparatus for measurement of blood substitutes | |
| WO2007001737A3 (en) | Methods and compositions for detecting herpes simplex virus type 2 | |
| DE60228952D1 (de) | Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren | |
| WO2002059600A3 (en) | Analyte detection | |
| WO2006004958A3 (en) | Detection or measurement of antibodies to antigenic proteins in biological tissues or samples | |
| EP1441224A3 (de) | Enzymhemmungsimmunverfahren | |
| DK1423708T3 (da) | Sammensætninger og fremgangsmåder til bestemmelser af AA4RP | |
| WO1998029726A3 (en) | Method of detecting and determining the concentration of total troponin i in a biological sample |